Celldex Therapeutics
CLDX
#4989
Rank
HK$9.94 B
Marketcap
HK$149.78
Share price
-1.38%
Change (1 day)
-48.33%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -HK$18.81

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$18.62. In 2022 the company made an earnings per share (EPS) of -HK$18.54 a decrease over its 2021 EPS that were of -HK$12.72.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$18.811.47%
2022-HK$18.5445.73%
2021-HK$12.72-23.36%
2020-HK$16.60-41.05%
2019-HK$28.16-76.95%
2018-HK$122.1745.03%
2017-HK$84.24-42.54%
2016-HK$146.60-3.82%
2015-HK$152.42-0.76%
2014-HK$153.5829.41%
2013-HK$118.680%
2012-HK$118.68-9.73%
2011-HK$131.471312.5%
2010-HK$9.31-95.79%
2009-HK$220.89-49.64%
2008-HK$438.63-82.64%
2007-HK$2,527-44.98%
2006-HK$4,5931270.83%
2005-HK$335.0833.33%
2004-HK$251.31-10%
2003-HK$279.24-16.67%
2002-HK$335.08-38.46%
2001-HK$544.51-4.88%
2000-HK$572.44-81.66%
1999-HK$3,120-87.2%
1998-HK$24,369206.39%
1997-HK$7,95413.02%
1996-HK$7,038

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$31.10 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$6.59-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$93.70 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.76-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.43-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.15-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$4.42-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA